Annual Retained Earnings
-$73.36 M
-$19.85 M-37.09%
April 30, 2024
Summary
- As of February 8, 2025, IPA annual retained earnings is -$73.36 million, with the most recent change of -$19.85 million (-37.09%) on April 30, 2024.
- During the last 3 years, IPA annual retained earnings has fallen by -$49.07 million (-202.04%).
- IPA annual retained earnings is now -2090.41% below its all-time high of -$3.35 million, reached on April 30, 2017.
Performance
IPA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$75.57 M
-$1.53 M-2.06%
October 31, 2024
Summary
- As of February 8, 2025, IPA quarterly retained earnings is -$75.57 million, with the most recent change of -$1.53 million (-2.06%) on October 31, 2024.
- Over the past year, IPA quarterly retained earnings has dropped by -$1.53 million (-2.06%).
- IPA quarterly retained earnings is now -2839.22% below its all-time high of -$2.57 million, reached on January 31, 2017.
Performance
IPA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
IPA Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.1% | -2.1% |
| 3 y3 years | -202.0% | -2.1% |
| 5 y5 years | -464.8% | -2.1% |
IPA Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -202.0% | at low | -130.3% | at low |
| 5 y | 5-year | -464.8% | at low | -370.6% | at low |
| alltime | all time | -2090.4% | at low | -2839.2% | at low |
ImmunoPrecise Antibodies Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | -$75.57 M(+2.1%) |
| Jul 2024 | - | -$74.04 M(+0.9%) |
| Apr 2024 | -$73.36 M(+37.1%) | -$73.36 M(+19.6%) |
| Jan 2024 | - | -$61.35 M(+7.0%) |
| Oct 2023 | - | -$57.33 M(-0.9%) |
| Jul 2023 | - | -$57.83 M(+8.1%) |
| Apr 2023 | -$53.51 M(+48.8%) | -$53.51 M(+5.4%) |
| Jan 2023 | - | -$50.77 M(+9.2%) |
| Oct 2022 | - | -$46.48 M(+7.8%) |
| Jul 2022 | - | -$43.13 M(+20.0%) |
| Apr 2022 | -$35.95 M(+48.0%) | -$35.95 M(+9.5%) |
| Jan 2022 | - | -$32.82 M(+6.9%) |
| Oct 2021 | - | -$30.71 M(+15.9%) |
| Jul 2021 | - | -$26.49 M(+9.1%) |
| Apr 2021 | -$24.29 M(+51.2%) | -$24.29 M(+25.3%) |
| Jan 2021 | - | -$19.39 M(+10.0%) |
| Oct 2020 | - | -$17.63 M(+2.7%) |
| Jul 2020 | - | -$17.16 M(+6.9%) |
| Apr 2020 | -$16.06 M(+23.6%) | -$16.06 M(-1.4%) |
| Jan 2020 | - | -$16.29 M(+2.6%) |
| Oct 2019 | - | -$15.88 M(+6.8%) |
| Jul 2019 | - | -$14.86 M(+14.4%) |
| Apr 2019 | -$12.99 M(+71.3%) | -$12.99 M(+25.2%) |
| Jan 2019 | - | -$10.37 M(+9.3%) |
| Oct 2018 | - | -$9.49 M(+14.0%) |
| Jul 2018 | - | -$8.32 M(+9.7%) |
| Apr 2018 | -$7.58 M(+126.3%) | -$7.58 M(+24.1%) |
| Jan 2018 | - | -$6.11 M(+23.9%) |
| Oct 2017 | - | -$4.93 M(+13.3%) |
| Jul 2017 | - | -$4.35 M(+29.9%) |
| Apr 2017 | -$3.35 M(-75.5%) | -$3.35 M(+30.3%) |
| Jan 2017 | - | -$2.57 M(-82.2%) |
| Sep 2016 | - | -$14.44 M(-1.6%) |
| Jun 2016 | - | -$14.67 M(+0.4%) |
| Mar 2016 | - | -$14.61 M(+6.9%) |
| Dec 2015 | -$13.66 M(-16.2%) | - |
| Dec 2015 | - | -$13.66 M(-3.1%) |
| Sep 2015 | - | -$14.09 M(-7.5%) |
| Jun 2015 | - | -$15.24 M(+2.1%) |
| Mar 2015 | - | -$14.93 M(-8.4%) |
| Dec 2014 | -$16.31 M(-8.0%) | - |
| Dec 2014 | - | -$16.31 M(-3.8%) |
| Sep 2014 | - | -$16.95 M(-4.3%) |
| Jun 2014 | - | -$17.70 M(+3.6%) |
| Mar 2014 | - | -$17.09 M(-3.6%) |
| Dec 2013 | -$17.72 M(-6.9%) | - |
| Dec 2013 | - | -$17.72 M(-2.9%) |
| Sep 2013 | - | -$18.25 M(+0.8%) |
| Jun 2013 | - | -$18.10 M(-3.0%) |
| Mar 2013 | - | -$18.65 M(-2.0%) |
| Dec 2012 | -$19.04 M(+3.1%) | - |
| Dec 2012 | - | -$19.04 M(-1.1%) |
| Sep 2012 | - | -$19.24 M(+5.5%) |
| Jun 2012 | - | -$18.24 M(-3.6%) |
| Mar 2012 | - | -$18.91 M(+2.5%) |
| Dec 2011 | -$18.46 M(-0.6%) | - |
| Dec 2011 | - | -$18.46 M(+2.3%) |
| Sep 2011 | - | -$18.04 M(-6.3%) |
| Jun 2011 | - | -$19.27 M(+0.7%) |
| Mar 2011 | - | -$19.14 M(+3.1%) |
| Dec 2010 | -$18.56 M | - |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | - | -$18.56 M(+42.4%) |
| Sep 2010 | - | -$13.04 M(+3.4%) |
| Jun 2010 | - | -$12.61 M(-4.1%) |
| Mar 2010 | - | -$13.15 M(+4.2%) |
| Dec 2009 | -$12.62 M(+26.4%) | - |
| Dec 2009 | - | -$12.62 M(+8.5%) |
| Sep 2009 | - | -$11.63 M(+9.1%) |
| Jun 2009 | - | -$10.65 M(+9.0%) |
| Mar 2009 | - | -$9.78 M(-2.1%) |
| Dec 2008 | -$9.98 M(-15.8%) | - |
| Dec 2008 | - | -$9.98 M(-11.7%) |
| Sep 2008 | - | -$11.30 M(-4.0%) |
| Jun 2008 | - | -$11.77 M(+0.9%) |
| Mar 2008 | - | -$11.67 M(-1.5%) |
| Dec 2007 | -$11.85 M(+24.8%) | - |
| Dec 2007 | - | -$11.85 M(+1.0%) |
| Sep 2007 | - | -$11.73 M(+7.4%) |
| Jun 2007 | - | -$10.92 M(+13.6%) |
| Mar 2007 | - | -$9.62 M(+1.3%) |
| Dec 2006 | -$9.49 M(+3.4%) | - |
| Dec 2006 | - | -$9.49 M(-3.6%) |
| Sep 2006 | - | -$9.85 M(+0.3%) |
| Jun 2006 | - | -$9.82 M(+7.0%) |
| Mar 2006 | - | -$9.18 M(+0.0%) |
| Dec 2005 | -$9.18 M(+1.8%) | - |
| Dec 2005 | - | -$9.18 M(-4.8%) |
| Sep 2005 | - | -$9.64 M(+7.7%) |
| Jun 2005 | - | -$8.95 M(-0.8%) |
| Mar 2005 | - | -$9.02 M(+0.1%) |
| Dec 2004 | -$9.01 M(+10.0%) | - |
| Dec 2004 | - | -$9.01 M(+5.7%) |
| Sep 2004 | - | -$8.53 M(+5.9%) |
| Jun 2004 | - | -$8.05 M(-1.4%) |
| Mar 2004 | - | -$8.17 M(-0.4%) |
| Dec 2003 | -$8.20 M(+28.3%) | - |
| Dec 2003 | - | -$8.20 M(+9.8%) |
| Sep 2003 | - | -$7.47 M(-0.4%) |
| Jun 2003 | - | -$7.49 M(+9.0%) |
| Mar 2003 | - | -$6.88 M(+7.6%) |
| Dec 2002 | -$6.39 M(+4.1%) | - |
| Dec 2002 | - | -$6.39 M(+1.6%) |
| Sep 2002 | - | -$6.28 M(-4.4%) |
| Jun 2002 | - | -$6.57 M(+6.7%) |
| Mar 2002 | - | -$6.16 M(+0.5%) |
| Dec 2001 | -$6.13 M(-3.7%) | - |
| Dec 2001 | - | -$6.13 M(-0.7%) |
| Sep 2001 | - | -$6.18 M(-3.0%) |
| Jun 2001 | - | -$6.37 M(+4.5%) |
| Mar 2001 | - | -$6.10 M(-4.3%) |
| Dec 2000 | -$6.37 M(-1.7%) | - |
| Dec 2000 | - | -$6.37 M(+0.7%) |
| Sep 2000 | - | -$6.32 M(-1.4%) |
| Jun 2000 | - | -$6.41 M(-1.5%) |
| Mar 2000 | - | -$6.51 M(+0.5%) |
| Dec 1999 | -$6.48 M(+22.7%) | - |
| Dec 1999 | - | -$6.48 M(+22.7%) |
| Dec 1998 | -$5.29 M(+9.3%) | - |
| Dec 1998 | - | -$5.29 M(+9.3%) |
| Dec 1997 | -$4.84 M(+7.4%) | - |
| Dec 1997 | - | -$4.84 M |
| Dec 1996 | -$4.50 M | - |
FAQ
- What is ImmunoPrecise Antibodies annual retained earnings?
- What is the all time high annual retained earnings for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies annual retained earnings year-on-year change?
- What is ImmunoPrecise Antibodies quarterly retained earnings?
- What is the all time high quarterly retained earnings for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies quarterly retained earnings year-on-year change?
What is ImmunoPrecise Antibodies annual retained earnings?
The current annual retained earnings of IPA is -$73.36 M
What is the all time high annual retained earnings for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high annual retained earnings is -$3.35 M
What is ImmunoPrecise Antibodies annual retained earnings year-on-year change?
Over the past year, IPA annual retained earnings has changed by -$19.85 M (-37.09%)
What is ImmunoPrecise Antibodies quarterly retained earnings?
The current quarterly retained earnings of IPA is -$75.57 M
What is the all time high quarterly retained earnings for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high quarterly retained earnings is -$2.57 M
What is ImmunoPrecise Antibodies quarterly retained earnings year-on-year change?
Over the past year, IPA quarterly retained earnings has changed by -$1.53 M (-2.06%)